BrainsWay (NASDAQ:BWAY – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Valuation and Earnings This table compares BrainsWay and INVO Bioscience’s […]
Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance […]
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, profitability and institutional ownership. Profitability This table compares Bluejay Diagnostics and INVO Bioscience’s […]
INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 71,800 shares, an increase of 22.5% from the April 30th total of 58,600 shares. Based on an average trading volume of 38,800 shares, the […]
Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, Zacks.com reports. The brokerage presently has a $3.00 price objective on the specialty chemicals company’s stock. Zacks Investment Research‘s target price would suggest a […]